What the Study Found (In Plain English)
Published in Cephalalgia : an international journal of headache (2004), this randomized controlled trial evaluating human clinical outcomes investigated: The present study examined the sensitivity to light of melatonin (MLT) secretion in familial migraine during a headache-free interval. Key clinical takeaway: - 6.7 +/- 5.8 pg/ml, P<0.05]. These findings show a clear hypersensitivity to light in young female migraineurs during the headache-free period.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (Cephalalgia : an international journal of headache, 2004-02-15; Randomized Controlled Trial; Rigor 88/100): - 6.7 +/- 5.8 pg/ml, P<0.05]. These findings show a clear hypersensitivity to light in young female migraineurs during the headache-free period.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.